Electric field helmet shows promise for kids with deadly brain cancer
NCT ID NCT03033992
First seen Mar 12, 2026 · Last updated Jun 23, 2026 · Updated 15 times
Summary
This study tests the Optune device, a wearable cap that creates low-intensity electric fields to disrupt cancer cell growth, in children with aggressive brain tumors. One group of children with recurrent high-grade glioma or ependymoma will use the device alone to see if it's feasible and safe. Another group of children with newly diagnosed DIPG will use the device alongside standard radiation therapy to see if the combination is feasible and may improve survival. The trial involves 80 children across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPENDYMOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90026, United States
-
Children's Hospital of Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010-2970, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Lucile Packard Children's Hospital at Stanford University Medical Center
Palo Alto, California, 94304, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Optune device (Tumor Treating Fields)
What this could lead to
If successful, this could provide a new, non-invasive treatment option for children with certain brain tumors, potentially improving survival when combined with radiation for DIPG.
What could go wrong
This is an early feasibility trial with a small number of participants, so results may not apply to all children. The device requires wearing it 18-22 hours daily, which may be challenging, and side effects or lack of benefit are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.